Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $11M | 8.9M | 1.21 |
| 2025-06-30 | $5.8M | 4.5M | 1.30 |
| 2025-03-31 | $6.9M | 6.0M | 1.15 |
| 2024-12-31 | $7.4M | 7.0M | 1.06 |
| 2024-09-30 | $7.0M | 6.0M | 1.17 |
| 2024-06-30 | $6.5M | 6.0M | 1.08 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1